论文部分内容阅读
目的观察氨溴特罗口服液辅助治疗小儿先天性心脏病合并肺炎的临床疗效。方法将符合诊断标准的32例病例随机分为治疗组16例,对照组16例。两组均给常规给氧、抗炎、雾化吸痰治疗。治疗组在此基础上加用口服氨溴特罗。对两组治疗效果进行比较。结果治疗组总有效率为93.8%,对照组总有效率为81.3%。经统计学比较差异有显著性(P<0.05)。结论论氨溴特罗辅助治疗小儿先天性心脏病(多血型)合并肺炎有效。
Objective To observe the clinical efficacy of ambroxol oral solution in the treatment of congenital heart disease complicated with pneumonia in children. Methods 32 cases meeting the diagnostic criteria were randomly divided into treatment group (16 cases) and control group (16 cases). Both groups were given conventional oxygen, anti-inflammatory, atomized suction treatment. On the basis of this, the treatment group plus oral administration of ambroxol. The treatment effect of the two groups were compared. Results The total effective rate was 93.8% in the treatment group and 81.3% in the control group. The statistical difference was significant (P <0.05). Conclusions On the efficacy of ambroxol in the treatment of children with congenital heart disease (multiple blood type) complicated with pneumonia.